Diabetes mellitus and multiple myeloma; common features of two distinct entities-Reference-Cited by-同舟云学术

Diabetes mellitus and multiple myeloma; common features of two distinct entities

Published:2022-05-25 Issue:5 Volume:38 Page:
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metabolism Res

Author:

Tentolouris Anastasios¹,Ntanasis‐Stathopoulos Ioannis²,Eleftheriadou Ioanna¹,Malandrakis Panagiotis²,Tzeravini Evangelia¹,Gavriatopoulou Maria²

Affiliation:

1. First Department of Propaedeutic Internal Medicine and Diabetes Center School of Medicine National and Kapodistrian University of Athens Laiko General Hospital Athens Greece

2. Department of Clinical Therapeutics School of Medicine National and Kapodistrian University of Athens Alexandra General Hospital Athens Greece

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dmrr.3535

Reference101 articles.

1. Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin and risk of hematological cancers in patients with diabetes: a systematic review and meta-analysis;Annals of Saudi Medicine;2024-03

2. Monoclonal Gammopathy of Undetermined Cardiovascular Significance; Current Evidence and Novel Insights;Journal of Cardiovascular Development and Disease;2023-12-04

3. Thiazolidinedione Use Is Associated with a Borderline Lower Risk of Multiple Myeloma and a Significantly Lower Risk of Death in Patients with Type 2 Diabetes Mellitus in Taiwan;Cancers;2023-08-26

4. Obesity and multiple myeloma: Emerging mechanisms and perspectives;Seminars in Cancer Biology;2023-07

5. The Risk of Multiple Myeloma Is Reduced in Metformin Initiators: A Retrospective Cohort Study in Taiwanese Patients with Type 2 Diabetes Mellitus;Cancers;2022-11-17